Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Kish Temple: First foundation of Christianity in CaucasusPodcasts have the last laugh as Colbert exitsOil pipeline ruptured in East Los AngelesCost of living angst pushes US consumer sentiment to record lowLe Pen: France Should Leave NATO CommandUSCIS: Green card applicants must return homeWhy is D Wave Quantum stock surging again today?Sarukyan supporters detained in ArmeniaKKR SWOT analysis: mixed signalsAzerbaijan thanked for innovative WUF13Kish Temple: First foundation of Christianity in CaucasusPodcasts have the last laugh as Colbert exitsOil pipeline ruptured in East Los AngelesCost of living angst pushes US consumer sentiment to record lowLe Pen: France Should Leave NATO CommandUSCIS: Green card applicants must return homeWhy is D Wave Quantum stock surging again today?Sarukyan supporters detained in ArmeniaKKR SWOT analysis: mixed signalsAzerbaijan thanked for innovative WUF13
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#fate-therapeutics

Latest news and interesting information about fate-therapeutics.

Fate Therapeutics CEO sells $54,482 in shares
Yesterday / 20:12
|
930

Fate Therapeutics CEO sells $54,482 in shares

Fate Therapeutics CEO Bahram Valamehr sold shares worth $54,482. Shares traded between $1.825 and $1.935. Company advances CAR T-cell therapy programs.

INSIDER TRADING →
0
...